Fingerprint Dive into the research topics of 'Targeting HER2 with T-DM1, an antibody cytotoxic drug conjugate, is effective in HER2 over expressing bladder cancer'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Targeting HER2 with T-DM1, an antibody cytotoxic drug conjugate, is effective in HER2 over expressing bladder cancer
Tetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo, Wolfgang Jäger, Igor Moskalev, Shannon Awrey, Takashi Dejima, Tilman Todenhöfer, Na Li, Ladan Fazli, Akio Matsubara, Peter C. Black
Research output: Contribution to journal › Article › peer-review
36
Citations
(Scopus)